This is a reminder that the Immune Tolerance Network (ITN) is currently seeking short "Concept Proposals" for novel combination therapy clinical trials designed to induce immune tolerance in allergy and asthma. The ITN is especially interested in the following:
1) Studies with a tolerance endpoint that combine allergen-specific approaches with other immunomodulatory agents
2) Development of novel tolerance assays to investigate allergen-specific mechanisms of clinical tolerance
The ideal proposal will have strong preclinical data, some safety and efficacy experience and a fully described, testable mechanism of tolerance induction. See additional details here.
Proposals should be submitted by August 17th, 2012 for a decision in October 2012. Please direct all proposal submissions and any questions concerning this RFP to Philip Bernstein, PhD, at pbernstein@immunetolerance.org.